TY  - CHAP
M1  - Book, Section
TI  - 18F-FDG PET/CT for Imaging Cardiac Sarcoidosis and Inflammation
A1  - Gallegos, Cesia
A1  - Young, Bryan D.
A1  - Miller, Edward J.
A2  - Heller, Gary V.
A2  - Hendel, Robert C.
PY  - 2022
T2  - Nuclear Cardiology: Practical Applications, 4e
AB  - KEY  POINTSFluorine-18  fluorodeoxyglucose  (18F-FDG)  positron  emission  tomography/computer  tomo-graphy  (PET/CT)  plays  a  critical  role  in  the  diagnosis  and  treatment  assessment  of  indivi  duals  with  suspected  or  known  cardiac  sarcoidosis  (CS)  and  is  included  in  diagnostic  algorithms  of  multisociety  guidelinesDiagnosis  of  active  inflammation  and  assessment  of  response  to  treatment  are  the  two  primary  indications  for  18F-FDG  PET/CT  in  CS.Cardiac  PET/CT  imaging  of  perfusion  and  metabolism  with  18F-FDG  has  the  potential  to  risk  stratify  patients  with  CS  for  future  cardiac  events.Several  studies  have  shown  the  usefulness  of  18F-FDG  PET/CT  as  an  additional  tool  in  detecting  infections  associated  with  devices  and  grafts,  now  incorporated  into  guidelines  for  the  management  of  infective  endocarditis.18F-FDG  PET/CT  has  high  sensitivity  to  detect  infection  in  challenging  causes  of  cardiac  device  infections  and  prosthetic  valves,  although  the  specificity  may  be  low,  particularly  in  the  early  postoperative  period.  
SN  - 
PB  - McGraw Hill LLC
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesscardiology.mhmedical.com/content.aspx?aid=1190157818
ER  -